Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

China Life Private Equity Investment

Investor type Private Equity Firm

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$42M
Portfolio companies 10
Lead investments 0
Exits 1
Key employees 7

Areas of investment

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Mobile Advertising
Summary

The leading representative office of defined VC is situated in the Beijing. The venture was found in Asia in China.

Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Harbour Biomed Among the most popular fund investment industries, there are Pharmaceutical, Energy. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.

The standard case for the fund is to invest in rounds with 4 partakers. Despite the China Life Private Equity Investment, startups are often financed by Legend Capital, Advantech Capital, CDH Investments. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures China, Vertex Ventures, SWFI.

The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of China Life Private Equity Investment:
Typical Co-investors
China Life Private Equity Investment is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after China Life Private Equity Investment:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Animal Capital California, Los Angeles, United States
BF Holdings Dudley, England, United Kingdom
Colony Latam Partners -
DFE Capital Management Arizona, Scottsdale, United States
Digital-Healthcare England, Leeds, United Kingdom
Elevation Capital Gurgaon, Haryana, India
ESM Japan Fukui, Fukui Prefecture, Japan
Frankford Re -
Haier Homecare -
Helios Enterprises -
Henley Ventures British Columbia, Canada, Surrey
Luminary Media Nusantara -
miHoYo China, Shanghai
Rosemark Capital Group New Jersey, Princeton, United States
Starwood Capital Group Connecticut, Greenwich, United States
Symbiosis Group -
Venrock Healthcare Partners California, Palo Alto, United States
Zhejiang Lipin Hangye Xiehui -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Hanbang Technology

Electronics
Industrial
Manufacturing
$46M13 Jun 2022 Zhangshan, Guangdong, China

Doma Biopharmaceutical

Biotechnology
$146M02 Jun 2022 Kagoshima, Kagoshima Prefecture, Japan

METiS Therapeutics

Biopharma
Biotechnology
Genetics
Health Care
$75M05 Apr 2022 Cambridge, Massachusetts, United States

Immunochina

Biotechnology
Clinical Trials
Medical
Medical Device
Pharmaceutical
24 Nov 2021 Dongcheng District, Beijing, China

SinoTau

Health Care
$49M21 Oct 2021 Dongcheng District, Beijing, China

GeneQuantum Healthcare

Health Care
Personal Health
Therapeutics
18 May 2021 Dongcheng District, Beijing, China

Biopharma
Biotechnology
Health Care
Life Science
$15M09 Mar 2020 China, Shanghai

Harbour Biomed

Biopharma
Biotechnology
Pharmaceutical
$85M27 Aug 2018 Shanghai, China

Wanka Online

Advertising
Mobile Advertising
Service Industry
Video Advertising
$4M22 Jun 2018 China, Beijing

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent China Life Private Equity Investment?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: